Fundz

Who to call at Cagent Vascular, and when

Fundz watches for the moments Cagent Vascular starts buying, and tells you who to reach.

  • An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cagent Vascular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchCagent Vascular, Inc. launches the POINT FORCE Registry to evaluate the safety and efficacy of the Serranator® PTA Serration Balloon Catheter.

Jan 28, 2025
WayneHealthcareHealth Care

Product Description

Cagent Vascular has initiated the POINT FORCE Registry, a post-market clinical study to assess the safety and efficacy of the Serranator® PTA Serration Balloon Catheter for treating Peripheral Artery Disease. This multicenter study will enroll at least 500 subjects across the United States.

Company Information

Company

Cagent Vascular

Location

150 STRAFFORD AVENUE

Wayne, Pennsylvania, United States

About

Cagent Vascular has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cagent Vascular ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Robert hidden

hidden
hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cagent Vascular's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Cagent Vascular shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.